Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure supports peptide coupling and is valuable in solid-phase peptide synthesis. Commonly employed in research settings for creating analogs in drug discovery programs targeting metabolic and viral diseases. The protecting group (Boc) allows for controlled reactivity during multi-step syntheses.